Learn more about how Q2 Solutions uses innovative anatomic pathology solutions and adjunct molecular services to help drug developers optimize outcomes and ensure success in clinical trials, regulatory approvals and new product launches.
Learn how Q2 recently modified the conventional SMART-Seq protocol, which led to an improved strategy for expression profiling via RNA sequencing from limiting amounts of RNA.
Local Chinese market knowledge with global experience to support your local, regional or global development program.
Full-service laboratory with specialty tuberculosis (TB) testing capabilities to support your study needs.
Learn about our ADME services, definitive in vitro assays, and metabolite profiling and identification services designed to meet the evolving needs of our customers.
Capabilities that accelerate preclinical studies.
Advanced methods to deliver consistent, reliable data.
Assays and services to accelerate the development of your pharmaceutical product.
A targeted sequencing assay for analysis of genomic variation predictive of response to therapies in clinical development.
Big data solutions and bioinformatics services for genomic insights.
|
|
|
|
|
|
|
|
|